# Intellia Therapeutics, Inc.: Form 8-K, filed Oct 29, 2025

- Company: [Intellia Therapeutics, Inc.](/companies/ntla.md) (CIK 1652130)
- Form: 8-K
- Filed: 2025-10-29
- Accepted by EDGAR: Oct 29, 2025, 16:22 ET
- Period: 2025-10-29
- Accession: 0001193125-25-256378
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1652130/000119312525256378/d98865d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652130/000119312525256378/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652130/000119312525256378/d98865d8k.htm

Filed Oct 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-256378. Last ingested by Listed: Nov 10, 2026, 17:10 ET. No prices; not investment advice.